Featured Research

from universities, journals, and other organizations

Study finds mixed results comparing two surgical strategies for infant heart defect

Date:
November 15, 2009
Source:
American Heart Association
Summary:
Researchers found mixed results in the first head-to-head comparison of two surgeries for infants born with severely underdeveloped hearts -- the most common severe heart birth defect. One surgery worked better initially but was associated with more complications, and by 2 years of age the survival advantage had disappeared. It remains to be seen which will prove better over the long term.

Infants born with a severely underdeveloped heart are more likely to survive to their first birthday when treated with a new shunt procedure -- yet it may not be the safest surgery long term, according to research presented at the American Heart Association's Scientific Sessions 2009.

Related Articles


Babies born with a critically underdeveloped left side of their hearts require three surgeries to correct the problem. A portion of the first operation, the Norwood Procedure, includes a connection to deliver blood from the heart to the pulmonary arteries feeding the lungs so that blood can pick up oxygen.

There are currently two ways it can be done:

  • The new modification of the Norwood utilizes a right ventricle to pulmonary artery (RV-to-PA) shunt to connect the functioning right ventricle to the pulmonary artery.
  • The traditional version uses a modified Blalock-Taussig shunt (MBTS), which connects the aorta (the major blood vessel delivering blood from the heart to the body) to the pulmonary artery.

In a 15-center trial by the Pediatric Heart Network, 555 infants (61 percent male, 73 percent Caucasian) were randomized to receive either the RV-to-PA shunt or MBTS procedure.

In the first results from the study, the researchers reported:

  • At 12 months, significantly more babies survived without requiring a heart transplant with the RV-to-PA shunt (74 percent) compared to the MBTS (64 percent, p=0.01).
  • The RV-to-PA shunt had more complications, necessitating 240 interventions (87.6 for every 100 babies), for example, to make adjustments to the shunt or use balloons or stents to keep it open. Far fewer cardiovascular interventions were needed (183, or 66.5 for every 100 babies) in the MBTS group (p=.006).
  • At an average of two years, the transplant-free survival advantage of RV-to-PA (68 percent) over MBTS (62 percent) had diminished and was no longer significant (p=0.14).

"Early results seem to favor the RV-PA shunt, but by two years there is no longer any survival advantage," said Richard G. Ohye, M.D., lead author of the study and associate professor of surgery at the University of Michigan Medical School in Ann Arbor. "It is still unknown which will turn out to be better over the long term."

For example, the children still must undergo other stages of surgical repair to increase the amount of oxygen in their blood. Good pulmonary artery growth is important in the success of this procedure. In the results so far, overall pulmonary artery growth was significantly greater after the MBTS.

"Ongoing surveillance as these children grow and undergo the final surgical procedure will be very important to determine the proper roles of the shunts," Ohye said.

Although rare, having a single working ventricle is the most common severe congenital heart defect.

"Just 25 to 30 years ago, this defect was uniformly fatal," Ohye said. "Now babies are treated with a series of three surgeries, but many still die, even when treated at experienced centers."

Each shunt procedure has theoretical advantages, but researchers previously didn't have hard evidence about which option to choose. The downside of the MBTS is that it takes blood away from the arteries feeding the heart muscle. The RV-to-PA shunt doesn't do this, but requires an incision into the baby's only working ventricle, creating scarring that might interfere with its later function.

"Roughly 50 percent of surgeons use each type, but we truly don't know which is better because there has never been a study," Ohye said. "In fact, there has never been a multi-center, randomized clinical trial performed in congenital heart surgery. This trial sets a new standard for using evidence-based medicine to evaluate new procedures in congenital heart surgery."

Co-authors are Sarah Tabbutt, M.D., Ph.D.; Lynn A. Sleeper, Sc.D.; Gail D. Pearson, M.D., Sc.D.; Lynn Mahony, M.D.; Jane W. Newburger, M.D., M.P.H.; Minmin Lu, Ph.D.; Peter C. Laussen, M.B.B.S.; Caren S. Goldberg, M.D., M.S.; Nancy W. Ghanayem, M.D.; Peter C. Frommelt, M.D.; Andrew M. Atz, M.D.; Steven Colan, M.D.; Jeffrey P. Jacobs, M.D.; James Jaggers, M.D.; Kirk R. Kanter, M.D.; Catherine Dent Krawczeski, M.D.; Alan B. Lewis, M.D.; Brian W. McCrindle, M.D., M.P.H.; L. LuAnn Minick, M.D.; Seema Mital, M.D.; Christian Pizarro, M.D.; Chitra Ravishankar, M.D.; Ismee A. Williams, M.D.; and J. William Gaynor, M.D. Author disclosures are on the abstract.

The National Heart, Lung, and Blood Institute funded the study.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Study finds mixed results comparing two surgical strategies for infant heart defect." ScienceDaily. ScienceDaily, 15 November 2009. <www.sciencedaily.com/releases/2009/11/091115191013.htm>.
American Heart Association. (2009, November 15). Study finds mixed results comparing two surgical strategies for infant heart defect. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2009/11/091115191013.htm
American Heart Association. "Study finds mixed results comparing two surgical strategies for infant heart defect." ScienceDaily. www.sciencedaily.com/releases/2009/11/091115191013.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins